Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02819011 · ClinicalTrials.gov registry record · Phase 2
OHI--Randomized Control Trial to Evaluate Efficacy, Acceptability, and Perception of Benefit of an Innovative Custom AFO
A Phase 2 study, sponsored by Bijan Najafi, PhD.
- Completed
- Registry status
- Phase 2
- Development phase
- 44
- Enrollment target
NCT02819011 is a Phase 2 study that has completed, run by Bijan Najafi, PhD. The registered enrollment target is 44 participants.
The verdict
NCT02819011, a Phase 2 study, has completed, sponsored by Bijan Najafi, PhD.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 44 participants
- Enrollment target
Study Summary
The investigators propose a randomized control trial to evaluate long term effects and effectiveness of Moore Balance Brace (MBB) ankle foot orthoses (AFO) in reducing risk of falling in older adults. Primary Endpoints • Characterize the impact of MBB AFO on balance, gait, risk of falling, frailty status, and adverse events Secondary Endpoints • Characterize the Impact of MBB AFO on spontaneous daily physical activities • Characterize the feasibility of the MBB AFO device on patient adherence, acceptability, user-friendliness, and perception of benefit for daily usage
Interventions
- OTHER Control
- DEVICE MBB AFO
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 44 participants |
| Start Date | 2016-05 |
| Est. Completion | 2019-04-04 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02819011
The ClinicalTrials.gov registry entry for NCT02819011 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 44 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Bijan Najafi, PhD, which has 5 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Control is the first listed.
NCT02819011 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02819011 about?
NCT02819011 is a clinical study titled "OHI--Randomized Control Trial to Evaluate Efficacy, Acceptability, and Perception of Benefit of an Innovative Custom AFO". The investigators propose a randomized control trial to evaluate long term effects and effectiveness of Moore Balance Brace (MBB) ankle foot orthoses (AFO) in reducing risk of falling in older adults. Primary Endpoints • Characterize the impact of MBB AFO on balance, gait, risk of falling, frailty ...
What is the current status of trial NCT02819011?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 44 participants. The study started on 2016-05. Estimated completion is 2019-04-04.
What interventions are being tested in trial NCT02819011?
The interventions under investigation include: Control (OTHER), MBB AFO (DEVICE).
Who is sponsoring clinical trial NCT02819011?
This trial is sponsored by Bijan Najafi, PhD, which has 5 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.